Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins

Annals of the New York Academy of Sciences

Volumn 1050, Issue , 2005, Pages 163-169

  Damoiseaux, Jan ^a   Jeyasekharan, A D ^a   Theunissen, R ^a   Tervaert, J W Cohen ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antiphospholipid syndrome; Atherosclerosis; Autoantibodies

Indexed keywords

CARDIOLIPIN ANTIBODY; COPPER ION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; CONFERENCE PAPER; CONJUGATION; CONTROLLED STUDY; CROSS REACTION; HUMAN; MAJOR CLINICAL STUDY; OXIDATION; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 23744472081     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1313.016     Document Type: Conference Paper

References (23)

1. WILSON, W.A., A.E. GHARAVI, T. KOIKE, et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42: 1309-1311.
2. HUGHE, G.R. 1993. The antiphospholipid syndrome: ten years on. Lancet 342: 341-344.
3. GALLI, M., P. COMFURIUS, C. MAASSEN, et al. 1990. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544-1547.
4. SALONEN, J.T., S. YLA-HERTTUALA, R. YAMAMOTO, et al. 1992. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883-837.
5. ARMSTRONG, V.W., E. WIELAND, F. DIEDRICH, et al. 1994. Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease. Lancet 343: 1570.
6. PUURUNEN, M., M. MANTTARI, V. MANNINEN, et al. 1994. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch. Intern. Med. 154: 2605-2609.
7. BERGMARK, C., R. WU, U. DE FAIRE, et al. 1995. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 15: 441-445.
8. VAARALA, O., G. ALFTHAN, M. JAUHIAINEN, et al. 1993. Crossreaction between anti-bodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 341: 923-925.
9. HORKKO, S., T. OLEE, L. MO, et al. 2001. Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein. Circulation 103: 941-946.
10. HORKKO, S., E. MILLER, D.W. BRANCH, et al. 1997. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and β2 glycoprotein 1 (and other proteins). Proc. Natl. Acad. Sci. USA 94: 10356-10361.
11. GILES, I.P., D.A. ISENBERG, D.S. LATCHMAN, et al. 2003. How do antiphospholipid anti-bodies bind β2-glycoprotein I? Arthritis Rheum. 48: 2111-2121.
12. KOBAYASHI, K., E. MATSUURA, Q. LIU, et al. 2001. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. J. Lipid Res. 42: 697-709.
13. REDGRAVE, T.G., D.C. ROBERTS & C.E. WEST. 1975. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
14. LOWRY, O.H., N.J. ROSEBROUGH, A.L. FARR, et al. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
15. PALINSKI, W., S. YLA-HERTTUALA, M.E. ROSENFELD, et al. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10: 325-335.
16. STEMME, S., B. FABER, J. HOLM, et al. 1995. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 92: 3893-3897.
17. SWETS, B.P., D.A. BROUWER & J.W. COHEN TERVAERT. 2001. Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL. Clin. Exp. Immunol. 124: 163-167.
18. NARVANEN, O., A. ERKKILA & S. YLA-HERTTUALA. 2001. Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL. Free Radic. Biol. Med. 31: 769-777.
19. TINCANI, A., F. ALLEGRI, M. SANMARCO, et al. 2001. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum. Thromb. Haemost. 86: 575-583.
20. ASANUMA, Y., A. OESER, A.K. SHINTANI, et al. 2003. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349: 2407-2415.
21. ROMAN, M.J., B.A. SHANKER, A. DAVIS, et al. 2003. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349: 2399-2406.
22. SHAW, P.X., S. HORKKO, M.K. CHANG, et al. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105: 1731-1740.
23. MATSUURA, E., K. KOBAYASHI, T. KOIKE, et al. 2002. Autoantibody-mediated atherosclerosis. Autoimmun. Rev. 1: 348-353.